| Literature DB >> 34713393 |
Ruo-Xi Zhang1, Dong-Mei Chen1, Yuan Qian1, Yu Sun1, Ru-Nan Zhu1, Fang Wang1, Ya-Xin Ding1, Qi Guo1, Yu-Tong Zhou1, Dong Qu2, Ling Cao3, Chun-Mei Zhu3, Lin-Qing Zhao4.
Abstract
BACKGROUND: A series of public health preventive measures has been widely implemented in Beijing to control the coronavirus disease-19 (COVID-19) pandemic since January 2020. An evaluation of the effects of these preventive measures on the spread of other respiratory viruses is necessary.Entities:
Keywords: Children; Coronavirus disease-19 (COVID-19); Human rhinovirus; Preventive measures; Respiratory viruses
Mesh:
Year: 2021 PMID: 34713393 PMCID: PMC8552974 DOI: 10.1007/s12519-021-00477-2
Source DB: PubMed Journal: World J Pediatr Impact factor: 9.186
Fig. 1Comparison of monthly distribution of several respiratory viruses (not all included) screened in the study based on the percentage of positive specimens in 2020 and the average during Jan 2017–Dec 2019. a The percentage of adenovirus (ADV)-positive specimens relative to the number of tests in 2020 (red curve) compared with the average value in 2017–2019 (grey curve); b the percentage of influenza (Flu)-positive specimens relative to the number of tests in 2020 (red curve) compared with the average value in 2017–2019 (grey curve); c the percentage of enterovirus (EV)/rhinoviruses (RV)-positive specimens relative to the number of tests in 2020 (red curve) compared with the average value in 2017–2019 (grey curve); d the percentage of respiratory syncytial virus (RSV)-positive specimens relative to the number of tests in 2020 (red curve) compared with the average value in 2017–2019 (grey curve)
Fig. 2Monthly distribution of rhinoviruses (RVs) from Jan 2017 to Dec 2020. The stacked column charts correspond to the left axis, indicating the number of positive specimens of various species of RVs in each month; the line graph corresponds to the right axis, indicating the number of specimens screened by the NxTAG™ RPP assays in each month
Clinical information for children positive for different species rhinoviruses (RVs) during 2017–2020
| 2017–2019 | 2020 | |||||
|---|---|---|---|---|---|---|
| Variables | RV-A | RV-B | RV-C | RV-A | RV-B | RV-C |
| Number | 299 | 69 | 226 | 153 | 25 | 120 |
| Male | 191 (63.9%) | 33 (47.8%) | 139 (57.1%) | 100 (65.4%) | 12 (48.0%) | 74 (61.7%) |
| Age of patients (years)a | 0.789 (0.228–2.657) | 1.632 (0.397–6.139) | 1.357 (0.489–3.567) | 2.504 (0.990–4.646) | 1.017 (0.386–5.432) | 2.073 (0.845–3.821) |
| The length of hospital stay (days)a | 7 (3–12) | 7 (5–12.75) | 7 (5–13) | 7 (3–12) | 6 (4–17) | 6 (5–11) |
aDescribed using the median and interquartile ranges
Fig. 3Weekly distribution of rhinoviruses (RVs) during Jan 2017–Dec 2020. a First-level public health emergency response was activated in Beijing, while a series of epidemic prevention measures had been implemented to restrict the outbreak of COVID-19; b the easing of the national lockdown, and some adults gradually were permitted to return to work; c the primary and secondary schools in Beijing were concurrently reopened. The gray line indicates the change in the weekly distribution of RV-positive rates from 2017 to 2019, and the red line indicates the change in the weekly distribution of RV-positive rates in 2020